School of Medicine
Showing 1-10 of 32 Results
Assistant Professor of Statistics and, by courtesy, of Computer Science
Bio My current research interests include statistical machine learning, high-dimensional statistics, algorithms and data structures, and concentration inequalities. Lately, I've been developing and analyzing algorithms for ranking, admixtures, matrix factorization, and collaborative filtering and crafting concentration inequalities for random matrices. I'm also organizing a working group on Statistics for Social Good. My interest lies, more generally, in problems that bridge applications and theory and that involve drawing inferences from large, structured datasets.
Quixotic though it may sound, I hope to use computer science and statistics to change the world for the better. If you have thoughts on how to do this, feel free to contact me.
Associate Professor (Research) of Microbiology and Immunology
Current Research and Scholarly Interests I'm interested in immune monitoring of T cell responses to chronic pathogens such as CMV, and the correlation of T cell response signatures with disease protection.
Professor of Pediatrics (Infectious Diseases) and of Health Research and Policy
Current Research and Scholarly Interests My research focuses on epidemiologic aspects of viral vaccines and perinatal HIV infection. This includes the molecular epidemiology of factors affecting the immunogenicity of oral polio vaccine (OPV) in developing areas of the world, and now the epidemiology of transmission and circulation of vaccine derived polioviruses in order to assist in global eradication of polio. I also work in development of methods to prevent breastfeeding transmission of HIV in Africa.
Sanjay V. Malhotra, PhD
Associate Professor (Research) of Radiation Oncology (Radiation and Cancer Biology) and of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly Interests My research interests focus on the design and discovery of synthetic, and natural product inspired small molecules which can be used as probes for developing understanding of biological phenomena, including protein-protein interactions and modulation of signal transduction pathways. My laboratory employs the tools of synthetic medicinal chemistry, molecular modeling and chemical biology for translational research in drug discovery, development, imaging and radiation.
Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital
Current Research and Scholarly Interests Germ cell tumors and bone sarcomas.
M. Peter Marinkovich, MD
Associate Professor of Dermatology
Current Research and Scholarly Interests The Marinkovich lab studies the function of epithelial extracellular matrix molecules, including integrins, collagens and laminins in epithelial development and carcinoma progression. We apply our discoveries in this area towards development of molecular therapies for carcinomas, hair disease and inherited epithelial adhesive disorders.
Associate Professor of Pediatrics (Cardiology) and of Bioengineering and, by courtesy, of Mechanical Engineering
Current Research and Scholarly Interests The Cardiovascular Biomechanics Computation Lab at Stanford develops novel computational methods for the study of cardiovascular disease progression, surgical methods, and medical devices. We have a particular interest in pediatric cardiology, and use virtual surgery to design novel surgical concepts for children born with heart defects.
Professor (Research) of Surgery (Transplantation)
Current Research and Scholarly Interests Host-Pathogen interactions; EBV B cell lymphomas; pathways of immune evasion in the growth and survival of EBV B cell lymphomas; mechanisms of graft rejection and tolerance induction; stem cell and solid organ transplantation.
Peter G Maxim
Assistant Professor of Radiation Oncology (Radiation Physics) at the Stanford University Medical Center
Current Research and Scholarly Interests My personal vision is the development of advanced, curative radiation therapy for all types and stages of malignancies, and new indications such as cardiovascular illnesses that will lead to increased survival worldwide from the top cancer and non-cancer causes of mortality.